PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genova, Italy.\', \'Department of Medical Oncology, Oncologia Medica 2, IRCCS Ospedale Policlinico San Martino, Genova, Italy.\', \'Department of Medical Oncology, U.O.C. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy.\', \'Interventional Pneumology Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy.\', \'Department of Health Sciences, University of Genova, Genova, Italy.\', \'Infectious Diseases Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy.\', \'UO Breast Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy.\', \'Department of Oncology, University of Turin and Mauriziano Hospital, Turin, Italy.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1111/eci.13315
?:hasPublicationType
?:journal
  • European journal of clinical investigation
is ?:pmid of
?:pmid
?:pmid
  • 32535890
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.321
?:rankingScore_hIndex
  • 94
is ?:relation_isRelatedTo_publication of
?:title
  • Italian survey on managing immune checkpoint inhibitors in oncology during COVID-19 outbreak.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all